Akiyo Takada1, Hajime Yokota2, Miho Watanabe Nemoto3, Takuro Horikoshi1, Jun Matsushima4, Takashi Uno3. 1. Department of Radiology, Chiba University Hospital, 1-8-1, Inohana, Chuo-ku, Chiba, Chiba, 260-8677, Japan. 2. Department of Diagnostic Radiology and Radiation Oncology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, Chiba, 260-8677, Japan. hjmykt@chiba-u.jp. 3. Department of Diagnostic Radiology and Radiation Oncology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, Chiba, 260-8677, Japan. 4. Department of Diagnostic Pathology, Chiba University Hospital, 1-8-1, Inohana, Chuo-ku, Chiba, Chiba, 260-8677, Japan.
Abstract
PURPOSE: This study aimed to identify the most appropriate volume of interest (VOI) setting in prognostic prediction using pretreatment magnetic resonance imaging (MRI) radiomic analysis for cervical cancer (CC) treated with definitive radiotherapy. MATERIALS AND METHODS: The study participants were 87 patients who had undergone pretreatment MRI and definitive radiotherapy for CC. VOItumor was created with tumor alone and VOI+4 mm-VOI+20 mm mechanically expanded by 4-20 mm around each VOItumor in axial T2-weighted images (T2WI) and an apparent diffusion coefficient (ADC) map. A model was constructed to predict recurrence within the irradiation field within 2 years after treatment using imaging features from the VOI of each sequence. Sorting ability was evaluated by area under the receiver operator characteristic curve (AUC-ROC) analysis. RESULTS: VOI expansion improved AUC-ROCs compared with the predictive models of VOItumor (0.59 and 0.67 in T2WI and ADC, respectively). The AUC-ROCs of the models with imaging features from expanded VOI+4 mm in T2WI and VOI+4 mm and VOI+8 mm in ADC were 0.82, 0.82, and 0.86, respectively. CONCLUSION: Recurrence could be predicted with high accuracy using expanded VOI for CC treated with definitive radiotherapy, suggesting that including the pathological characteristics of invasive margins in radiomics may improve predictive ability.
PURPOSE: This study aimed to identify the most appropriate volume of interest (VOI) setting in prognostic prediction using pretreatment magnetic resonance imaging (MRI) radiomic analysis for cervical cancer (CC) treated with definitive radiotherapy. MATERIALS AND METHODS: The study participants were 87 patients who had undergone pretreatment MRI and definitive radiotherapy for CC. VOItumor was created with tumor alone and VOI+4 mm-VOI+20 mm mechanically expanded by 4-20 mm around each VOItumor in axial T2-weighted images (T2WI) and an apparent diffusion coefficient (ADC) map. A model was constructed to predict recurrence within the irradiation field within 2 years after treatment using imaging features from the VOI of each sequence. Sorting ability was evaluated by area under the receiver operator characteristic curve (AUC-ROC) analysis. RESULTS: VOI expansion improved AUC-ROCs compared with the predictive models of VOItumor (0.59 and 0.67 in T2WI and ADC, respectively). The AUC-ROCs of the models with imaging features from expanded VOI+4 mm in T2WI and VOI+4 mm and VOI+8 mm in ADC were 0.82, 0.82, and 0.86, respectively. CONCLUSION: Recurrence could be predicted with high accuracy using expanded VOI for CC treated with definitive radiotherapy, suggesting that including the pathological characteristics of invasive margins in radiomics may improve predictive ability.
Entities:
Keywords:
In-field recurrence; Machine learning; Prognosis; Radiomics; Uterine cervical cancer
Authors: Philippe Lambin; Emmanuel Rios-Velazquez; Ralph Leijenaar; Sara Carvalho; Ruud G P M van Stiphout; Patrick Granton; Catharina M L Zegers; Robert Gillies; Ronald Boellard; André Dekker; Hugo J W L Aerts Journal: Eur J Cancer Date: 2012-01-16 Impact factor: 9.162
Authors: Maarten G Thomeer; Cees Gerestein; Sandra Spronk; Helena C van Doorn; Els van der Ham; Myriam G Hunink Journal: Eur Radiol Date: 2013-03-01 Impact factor: 5.315
Authors: Baderaldeen A Altazi; Daniel C Fernandez; Geoffrey G Zhang; Samuel Hawkins; Syeda M Naqvi; Youngchul Kim; Dylan Hunt; Kujtim Latifi; Matthew Biagioli; Puja Venkat; Eduardo G Moros Journal: Phys Med Date: 2018-02-21 Impact factor: 2.685
Authors: Nathaniel M Braman; Maryam Etesami; Prateek Prasanna; Christina Dubchuk; Hannah Gilmore; Pallavi Tiwari; Donna Plecha; Anant Madabhushi Journal: Breast Cancer Res Date: 2017-05-18 Impact factor: 6.466
Authors: Zhiguo Zhou; Genevieve M Maquilan; Kimberly Thomas; Jason Wachsmann; Jing Wang; Michael R Folkert; Kevin Albuquerque Journal: Technol Cancer Res Treat Date: 2020 Jan-Dec